# Title
Atorvastatin B-Chemical
glucuronidation O
is O
minimally O
and O
nonselectively O
inhibited O
by O
the O
fibrates B-Chemical
gemfibrozil, B-Chemical
fenofibrate, B-Chemical
and O
fenofibric B-Chemical
acid. I-Chemical

# Abstract
Gemfibrozil B-Chemical
coadministration O
generally O
results O
in O
plasma O
statin O
area O
under O
the O
curve O
(AUC) O
increases, O
ranging O
from O
moderate O
(2- O
to O
3-fold) O
with O
simvastatin, B-Chemical
lovastatin, B-Chemical
and O
pravastatin B-Chemical
to O
most O
significant O
with O
cerivastatin B-Chemical
(5.6-fold). O
Inhibition O
of O
statin O
glucuronidation O
has O
been O
postulated O
as O
a O
potential O
mechanism O
of O
interaction O
(Drug O
Metab O
Dispos O
30:1280-1287, O
2002). O
This O
study O
was O
conducted O
to O
determine O
the O
in O
vitro O
inhibitory O
potential O
of O
fibrates B-Chemical
toward O
atorvastatin B-Chemical
glucuronidation. O
[(3)H]Atorvastatin, O
atorvastatin, B-Chemical
and O
atorvastatin B-Chemical
lactone I-Chemical
were O
incubated O
with O
human B-Species
liver O
microsomes O
or O
human B-Species
recombinant O
UDP-glucuronosyltransferases O
(UGTs) O
and O
characterized O
using O
liquid O
chromatography O
(LC) O
tandem O
mass O
spectrometry O
and O
LC O
UV O
beta-radioactivity O
monitor O
mass O
spectrometry. O
[(3)H]Atorvastatin O
yields O
a O
minor O
ether B-Chemical
glucuronide I-Chemical
(G1) O
and O
a O
major O
acyl B-Chemical
glucuronide I-Chemical
(G2) O
with O
subsequent O
pH-dependent O
lactonization O
of O
G2 O
to O
yield O
atorvastatin B-Chemical
lactone. I-Chemical
Atorvastatin B-Chemical
lactonization O
best O
fit O
substrate O
inhibition O
kinetics O
(K(m) O
= O
12 O
microM, O
V(max) O
= O
74 O
pmol O
min O
mg, O
K(i) O
= O
75 O
microM). O
Atorvastatin B-Chemical
lactone I-Chemical
yields O
a O
single O
ether B-Chemical
glucuronide I-Chemical
(G3). B-Chemical
G3 B-Chemical
formation O
best O
fit O
Michaelis-Menten O
kinetics O
(K(m) O
= O
2.6 O
microM, O
V(max) O
= O
10.6 O
pmol O
min O
mg). O
Six O
UGT B-Gene
enzymes O
contribute O
to O
atorvastatin B-Chemical
glucuronidation O
with O
G2 O
and O
G3 B-Chemical
formation O
catalyzed O
by O
UGTs O
1A1, O
1A3, O
1A4, O
1A8, O
and O
2B7, O
whereas O
G1 O
formation O
was O
catalyzed O
by O
UGTs O
1A3, O
1A4, O
and O
1A9. O
Gemfibrozil, B-Chemical
fenofibrate, B-Chemical
and O
fenofibric B-Chemical
acid I-Chemical
inhibited O
atorvastatin B-Chemical
lactonization O
with O
IC(50) O
values O
of O
346, O
320, O
and O
291 O
microM, O
respectively. O
Based O
on O
unbound O
fibrate B-Chemical
concentrations O
at O
the O
inlet O
to O
the O
liver, O
these O
data O
predict O
a O
small O
increase O
in O
atorvastatin B-Chemical
AUC O
(approximately O
1.2-fold) O
after O
gemfibrozil B-Chemical
coadministration O
and O
no O
interaction O
with O
fenofibrate. B-Chemical
This O
result O
is O
consistent O
with O
recent O
clinical O
reports O
indicating O
minimal O
atorvastatin B-Chemical
AUC O
increases O
( O
approximately O
1.2- O
to O
1.4-fold) O
with O
gemfibrozil. B-Chemical